Innoviva, Inc. financial data

Symbol
INVA on Nasdaq
Industry
Pharmaceutical Preparations
Location
1350 Old Bayshore Highway, Suite 400, Burlingame, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
THERAVANCE INC (to 12/7/2015), ADVANCED MEDICINE INC (to 8/2/2000)
Latest financial report
10-K - Q4 2024 - Feb 26, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 314 % -62.5%
Quick Ratio 27.4 % -76.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 62.7M shares -0.87%
Common Stock, Shares, Outstanding 62.7M shares -1.01%
Entity Public Float 899M USD
Common Stock, Value, Issued 627K USD -0.95%
Weighted Average Number of Shares Outstanding, Basic 62.7M shares -4.14%
Weighted Average Number of Shares Outstanding, Diluted 74.2M shares -14.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 359M USD +15.5%
Research and Development Expense 13.7M USD -59.7%
Costs and Expenses 321M USD +176%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 37.4M USD -80.7%
Income Tax Expense (Benefit) 14M USD -2.64%
Earnings Per Share, Basic 0.37 USD/shares -86.5%
Earnings Per Share, Diluted 0.36 USD/shares -83.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 305M USD +57.6%
Inventory, Net 33.7M USD -17.2%
Other Assets, Current 656K USD -84.6%
Assets, Current 554M USD +61%
Deferred Income Tax Assets, Net 12.1M USD
Property, Plant and Equipment, Net 514K USD +6.42%
Operating Lease, Right-of-Use Asset 2.45M USD -3.27%
Intangible Assets, Net (Excluding Goodwill) 208M USD -9.51%
Goodwill 17.9M USD 0%
Other Assets, Noncurrent 41.5M USD +1170%
Assets 1.3B USD +4.63%
Accounts Payable, Current 2.13M USD -68.3%
Employee-related Liabilities, Current 7.38M USD +5.07%
Liabilities, Current 236M USD +519%
Accrued Income Taxes, Noncurrent 53.2M USD +353%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 1.18M USD -27.9%
Other Liabilities, Noncurrent 64.3M USD -10.6%
Retained Earnings (Accumulated Deficit) -22.1M USD +74.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 691M USD +2.4%
Liabilities and Equity 1.3B USD +4.63%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 37M USD +44.2%
Net Cash Provided by (Used in) Financing Activities -9.17M USD +93.3%
Net Cash Provided by (Used in) Investing Activities -43M USD -20.5%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 62.7M shares -1.01%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -15.2M USD +89.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 305M USD +57.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.18M USD -16.5%
Deferred Tax Assets, Valuation Allowance 188M USD +10.9%
Deferred Tax Assets, Gross 234M USD +2.72%
Operating Lease, Liability 2.75M USD -3.2%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 180M USD -16%
Lessee, Operating Lease, Liability, to be Paid 3M USD -2.88%
Operating Lease, Liability, Current 1.57M USD +30.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 435K USD -69.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.71M USD +24.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure
Deferred Income Tax Expense (Benefit) 3.24M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 253K USD +0.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 455K USD +218%
Deferred Tax Assets, Operating Loss Carryforwards 177M USD -2.76%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 230K shares 0%
Unrecognized Tax Benefits 61.3M USD +215%
Lessee, Operating Lease, Liability, to be Paid, Year Four 326K USD
Operating Lease, Payments 320K USD -17.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 25.9M USD +18.9%
Deferred Tax Assets, Net of Valuation Allowance 46.5M USD -20.8%
Share-based Payment Arrangement, Expense 6.37M USD +9.2%
Interest Expense 22.2M USD +15.9%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%